Intuitive Surgical Inc. Insider Trading

ISRG

Last 12 months

Insiders sold $69M and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Nov 2010.

Net open-market

−$69M

0 buys · 47 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 11

executives and directors

Last open-market buy

Nov 2010

Nov 19, 2010

Get an email when ISRG's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 29 – 30	Mark Brosius EVP & Chief Mfg and Supply Cha	Sold10b5-1 plan 2 parts	124	$450.77 average	56K	21%	Form 4
Oct 30	Fredrik Widman VP Corporate Controller	Sold10b5-1 plan	5,448	$436.06	$2.38M	84%	Form 4
Oct 26 – 28	Mark Brosius EVP & Chief Mfg and Supply Cha	Sold10b5-1 plan 3 parts	183	$448.33 average	82K	24%	Form 4
Oct 23	Craig H Barratt Director	Sold10b5-1 plan	1,150	$443.80	510K	4.0%	Form 4
Oct 23	Fredrik Widman VP Corporate Controller	Sold10b5-1 plan	4,047	$453.21	$1.83M	80%	Form 4
Oct 23	Patricia L Wadors SVP Chief Human Resources Offi	Sold10b5-1 plan	1,078	$443.80	478K	100%	Form 4
Oct 23	Gary S Guthart Director	Sold10b5-1 plan	20,095	$451.61	$9.08M	1.6%	Form 4
Sep 15	Fredrik Widman VP Corporate Controller	Sold10b5-1 plan 2 parts	1,089	$374.44 average	408K	51%	Form 4
Sep 10 – 11	Mark Brosius EVP & Chief Mfg and Supply Cha	Sold10b5-1 plan 2 parts	48	$357.10 average	17K	5.9%	Form 4
Sep 8 – 9	Mark Brosius EVP & Chief Mfg and Supply Cha	Sold10b5-1 plan 2 parts	69	$357.55 average	25K	7.8%	Form 4
Aug 20 – 21	Mark Brosius EVP & Chief Mfg and Supply Cha	Sold10b5-1 plan 2 parts	154	$385.97 average	59K	15%	Form 4
Aug 17 – 19	Mark Brosius EVP & Chief Mfg and Supply Cha	Sold10b5-1 plan 3 parts	231	$392.98 average	91K	18%	Form 4
Aug 11	Gary S Guthart Director	Sold10b5-1 plan	10,000	$400.00	$4M	0.8%	Form 4
Aug 10 – 11	Amy L Ladd Director	Sold10b5-1 plan 2 parts	472	$381.15 average	180K	73%	Form 4
Aug 10	Gary Loeb EVP & Chief Legal and Complian	Sold10b5-1 plan	400	$379.00	152K	7.0%	Form 4
Jul 30 – 31	Mark Brosius EVP & Chief Mfg and Supply Cha	Sold10b5-1 plan 2 parts	56	$348.91 average	20K	4.2%	Form 4
Jul 27 – 29	Mark Brosius EVP & Chief Mfg and Supply Cha	Sold10b5-1 plan 3 parts	84	$356.60 average	30K	6.0%	Form 4
Jun 11 – 12	Mark Brosius EVP & Chief Mfg and Supply Cha	Sold10b5-1 plan 2 parts	48	$413.19 average	20K	3.3%	Form 4
Jun 8 – 10	Mark Brosius EVP & Chief Mfg and Supply Cha	Sold10b5-1 plan 3 parts	69	$421.80 average	29K	4.5%	Form 4
Jun 10	Gary Loeb EVP & Chief Legal and Complian	Sold10b5-1 plan	400	$424.14	170K	6.5%	Form 4
Jun 1	Iman Jeddi SVP & GM da Vinci Platforms &	Sold10b5-1 plan	5,625	$420.55	$2.37M	15%	Form 4
May 21 – 22	Mark Brosius EVP & Chief Mfg and Supply Cha	Sold10b5-1 plan 2 parts	36	$442.92 average	16K	2.3%	Form 4
May 18 – 20	Mark Brosius EVP & Chief Mfg and Supply Cha	Sold10b5-1 plan 3 parts	54	$434.52 average	23K	3.3%	Form 4
May 11	Gary Loeb EVP & Chief Legal and Complian	Sold10b5-1 plan	400	$446.95	179K	6.1%	Form 4
Apr 28 – 29	Amy L Ladd Director	Sold10b5-1 plan 2 parts	619	$471.55 average	292K	84%	Form 4
Mar 10	Myriam Curet EVP & Chief Medical Officer	Sold10b5-1 plan	105	$493.95	52K	20%	Form 4
Mar 6 – 9	Mark Brosius SVP & Chief Mfg and Supply Cha	Sold10b5-1 plan 2 parts	1,293	$487.61 average	630K	44%	Form 4
Mar 3 – 5	Mark Brosius SVP & Chief Mfg and Supply Cha	Sold10b5-1 plan 3 parts	3,658	$496.19 average	$1.82M	56%	Form 4
Feb 27 – Mar 3	Fredrik Widman VP Corporate Controller	Sold10b5-1 plan 2 parts	367	$495.68 average	182K	26%	Form 4
Mar 2 – 3	Myriam Curet EVP & Chief Medical Officer	Sold10b5-1 plan 2 parts	4,853	$487.32 average	$2.36M	92%	Form 4
Feb 27	Myriam Curet EVP & Chief Medical Officer	Sold10b5-1 plan	2,345	$499.71	$1.17M	31%	Form 4
Feb 27	Patricia L Wadors SVP Chief Human Resources Offi	Sold10b5-1 plan	220	$499.71	110K	100%	Form 4
Feb 11	Fredrik Widman VP Corporate Controller	Sold10b5-1 plan	133	$494.96	66K	17%	Form 4
Feb 10 – 11	Myriam Curet EVP & Chief Medical Officer	Sold10b5-1 plan 2 parts	526	$494.90 average	260K	56%	Form 4
Jan 29	Myriam Curet EVP & Chief Medical Officer	Sold10b5-1 plan	126	$520.02	66K	26%	Form 4
Jan 27	Myriam Curet EVP & Chief Medical Officer	Sold10b5-1 plan 2 parts	230	$532.61 average	123K	39%	Form 4
Jan 27	Gary S Guthart Director	Sold10b5-1 plan 3 parts	27,300	$530.25 average	$14.5M	2.1%	Form 4
Dec 15, 2025	Mark Brosius See Remarks	Sold10b5-1 plan	464	$548.49	254K	78%	Form 4
Dec 12, 2025	Mark Brosius See Remarks	Sold10b5-1 plan	312	$547.36	171K	34%	Form 4
Dec 10, 2025	Myriam Curet EVP & Chief Medical Officer	Sold10b5-1 plan	104	$559.90	58K	23%	Form 4

Oct 29 – 3010b5-1 plan
Mark Brosius
EVP & Chief Mfg and Supply Cha · sold 124 at avg $450.77
56K
21% of stake
Oct 3010b5-1 plan
Fredrik Widman
VP Corporate Controller · sold 5,448 at $436.06
$2.38M
84% of stake
Oct 26 – 2810b5-1 plan
Mark Brosius
EVP & Chief Mfg and Supply Cha · sold 183 at avg $448.33
82K
24% of stake
Oct 2310b5-1 plan
Craig H Barratt
Director · sold 1,150 at $443.80
510K
4.0% of stake
Oct 2310b5-1 plan
Fredrik Widman
VP Corporate Controller · sold 4,047 at $453.21
$1.83M
80% of stake
Oct 2310b5-1 plan
Patricia L Wadors
SVP Chief Human Resources Offi · sold 1,078 at $443.80
478K
100% of stake
Oct 2310b5-1 plan
Gary S Guthart
Director · sold 20,095 at $451.61
$9.08M
1.6% of stake
Sep 1510b5-1 plan
Fredrik Widman
VP Corporate Controller · sold 1,089 at avg $374.44
408K
51% of stake
Sep 10 – 1110b5-1 plan
Mark Brosius
EVP & Chief Mfg and Supply Cha · sold 48 at avg $357.10
17K
5.9% of stake
Sep 8 – 910b5-1 plan
Mark Brosius
EVP & Chief Mfg and Supply Cha · sold 69 at avg $357.55
25K
7.8% of stake
Aug 20 – 2110b5-1 plan
Mark Brosius
EVP & Chief Mfg and Supply Cha · sold 154 at avg $385.97
59K
15% of stake
Aug 17 – 1910b5-1 plan
Mark Brosius
EVP & Chief Mfg and Supply Cha · sold 231 at avg $392.98
91K
18% of stake
Aug 1110b5-1 plan
Gary S Guthart
Director · sold 10,000 at $400.00
$4M
0.8% of stake
Aug 10 – 1110b5-1 plan
Amy L Ladd
Director · sold 472 at avg $381.15
180K
73% of stake
Aug 1010b5-1 plan
Gary Loeb
EVP & Chief Legal and Complian · sold 400 at $379.00
152K
7.0% of stake
Jul 30 – 3110b5-1 plan
Mark Brosius
EVP & Chief Mfg and Supply Cha · sold 56 at avg $348.91
20K
4.2% of stake
Jul 27 – 2910b5-1 plan
Mark Brosius
EVP & Chief Mfg and Supply Cha · sold 84 at avg $356.60
30K
6.0% of stake
Jun 11 – 1210b5-1 plan
Mark Brosius
EVP & Chief Mfg and Supply Cha · sold 48 at avg $413.19
20K
3.3% of stake
Jun 8 – 1010b5-1 plan
Mark Brosius
EVP & Chief Mfg and Supply Cha · sold 69 at avg $421.80
29K
4.5% of stake
Jun 1010b5-1 plan
Gary Loeb
EVP & Chief Legal and Complian · sold 400 at $424.14
170K
6.5% of stake
Jun 110b5-1 plan
Iman Jeddi
SVP & GM da Vinci Platforms & · sold 5,625 at $420.55
$2.37M
15% of stake
May 21 – 2210b5-1 plan
Mark Brosius
EVP & Chief Mfg and Supply Cha · sold 36 at avg $442.92
16K
2.3% of stake
May 18 – 2010b5-1 plan
Mark Brosius
EVP & Chief Mfg and Supply Cha · sold 54 at avg $434.52
23K
3.3% of stake
May 1110b5-1 plan
Gary Loeb
EVP & Chief Legal and Complian · sold 400 at $446.95
179K
6.1% of stake
Apr 28 – 2910b5-1 plan
Amy L Ladd
Director · sold 619 at avg $471.55
292K
84% of stake
Mar 1010b5-1 plan
Myriam Curet
EVP & Chief Medical Officer · sold 105 at $493.95
52K
20% of stake
Mar 6 – 910b5-1 plan
Mark Brosius
SVP & Chief Mfg and Supply Cha · sold 1,293 at avg $487.61
630K
44% of stake
Mar 3 – 510b5-1 plan
Mark Brosius
SVP & Chief Mfg and Supply Cha · sold 3,658 at avg $496.19
$1.82M
56% of stake
Feb 27 – Mar 310b5-1 plan
Fredrik Widman
VP Corporate Controller · sold 367 at avg $495.68
182K
26% of stake
Mar 2 – 310b5-1 plan
Myriam Curet
EVP & Chief Medical Officer · sold 4,853 at avg $487.32
$2.36M
92% of stake
Feb 2710b5-1 plan
Myriam Curet
EVP & Chief Medical Officer · sold 2,345 at $499.71
$1.17M
31% of stake
Feb 2710b5-1 plan
Patricia L Wadors
SVP Chief Human Resources Offi · sold 220 at $499.71
110K
100% of stake
Feb 1110b5-1 plan
Fredrik Widman
VP Corporate Controller · sold 133 at $494.96
66K
17% of stake
Feb 10 – 1110b5-1 plan
Myriam Curet
EVP & Chief Medical Officer · sold 526 at avg $494.90
260K
56% of stake
Jan 2910b5-1 plan
Myriam Curet
EVP & Chief Medical Officer · sold 126 at $520.02
66K
26% of stake
Jan 2710b5-1 plan
Myriam Curet
EVP & Chief Medical Officer · sold 230 at avg $532.61
123K
39% of stake
Jan 2710b5-1 plan
Gary S Guthart
Director · sold 27,300 at avg $530.25
$14.5M
2.1% of stake
Dec 15, 202510b5-1 plan
Mark Brosius
See Remarks · sold 464 at $548.49
254K
78% of stake
Dec 12, 202510b5-1 plan
Mark Brosius
See Remarks · sold 312 at $547.36
171K
34% of stake
Dec 10, 202510b5-1 plan
Myriam Curet
EVP & Chief Medical Officer · sold 104 at $559.90
58K
23% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ISRG, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Pick stocks to compare with ISRG

CompareIntrinsic value

ZBHZimmer Biomet Holdings, Inc.

$110.15+13.49%66

EWEdwards Lifesciences Corporation

$99.37+4.39%60

STESTERIS plc

$247.91+7.16%70

ALGNAlign Technology, Inc.

$164.90+8.79%66

ENOVEnovis Corporation

$24.42+16.90%42

MSAMsa Safety Inc.

$177.60+2.03%75

BAXBaxter International Inc.

$26.50+3.96%32

SOLVSolventum Corporation

$89.35+5.42%38

Held by ETFs

ISRG is in 375 US ETFs. The largest of them, with ISRG's weight in each:

Spot a number that looks wrong? Check it in ISRG's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ISRG

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.